Syndax Pharmaceuticals
SNDX
SNDX
74 hedge funds and large institutions have $68.9M invested in Syndax Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 75 → 74 (-1)
3.38% less ownership
Funds ownership: 65.66% → 62.28% (-3.4%)
44% less capital invested
Capital invested by funds: $124M → $68.9M (-$55.1M)
Holders
74
Holding in Top 10
1
Calls
$2.05M
Puts
$290K
Top Buyers
| 1 | +$3.66M | |
| 2 | +$3.36M | |
| 3 | +$788K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$758K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$499K |
Top Sellers
| 1 | -$2.82M | |
| 2 | -$2.49M | |
| 3 | -$1.37M | |
| 4 |
O
OrbiMed
New York
|
-$1M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$823K |